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Theliverexecutesamultitudeoffunctionsinhumanphysiology
such as detoxiﬁcation or hormone synthesis. Consequently,
hepaticdysfunction,beitinbornoracquired,canleadtodiverse
pathological manifestations as for instance argininemia or
hypercholesterolemia. To analyze liver function at the cellular
scale and to investigate underlying genotype–phenotype
relationships, a growing number of high-throughput data has
beengeneratedinrecentyears.However,mechanisticcomputa-
tional models are equally important in order to interpret and
contextualize this data and toobtaina holisticunderstanding of
human liver functionality per se.
In a ﬁrst attempt to capture human metabolism in a rigorous
quantitativesense,twogenericstoichiometricmodelsatgenome
scale have been developed recently(Duarte et al, 2007; Ma et al,
2007). They correlate pathway information with gene annota-
tion thereby describing basic metabolic biochemistry. These
models successfully identiﬁed selected drug targets, whereas
investigation of tissue-speciﬁc metabolism was only possible by
additionally considering gene-expression measurements, which
revealed ﬂux activity of disease-related enzymes in different
organs (Shlomi et al, 2008). This approach, however, cannot
compensate for the lacking tissue-speciﬁc metabolic networks,
which are essential to analyze modes of drug action by probing
strategies of structural network intervention in silico.
Nowtworesearch groups have overcome this limitation and
independently developed genome-scale stoichiometric models
of human liver metabolism, thus allowing in-depth mechani-
stic insights into hepatic functioning (Gille et al, 2010; Jerby
et al, 2010). Interestingly, the approaches for network
reconstruction chosen by the respective groups are fairly
different even though both have started from the same generic
metabolic models. Gille et al performed a large-scale analysis
of bibliomic data and subsequently reconciled the network
named HepatoNet1 by hand. In comparison, Jerby et al used a
model-building algorithm (MBA) for network reconstruction,
which has a broad applicability to generic models in general.
Regarding the resulting compartmentalization, both models
consider cytosol, mitochondria, lysosome, endoplasmatic
reticulum and nucleus, but peroxisome, bile canaliculus and
sinusoidal space are unique to HepatoNet1, whereas the MBA-
based model includes a generic extracellular space. This
divergence in overall model structure is also reﬂected in the
total number of network reactions, which is higher for
HepatoNet1 (2539 versus 1827 reactions), albeit a direct
comparison of both models is difﬁcult due to different
exchange reactions and compound names. In this respect,
development of a consensus network such as previously
undertaken for yeast (Herrgard et al, 2008) will be a rewarding
endeavor for the future.
Both models were subsequently tested for an accurate
description of both gluconeogenesis and detoxiﬁcation of
ammonia,twocentralfunctionsoflivermetabolism.Inaddition,
Gille et al show the accuracy of their model by validating
the fulﬁllment of 442 metabolic tasks of various degrees of
complexity. These can be considered as hepatic equivalents to
simpler cellular objective functions identiﬁed in microbial cells
(Schuetz et al, 2007). Jerby et al implicitly account for similar
information, though presumably to a lesser extent, by structural
inclusion of tissue-speciﬁc ‘omics’ data and additionally
evaluate the validity of their model by predicting hepatic ﬂux
distributions and metabolic biomarkers. Finally, both groups
compare the predictive performance of their hepatic models to
the earlier generic models of human metabolism and demon-
strate a considerable improvement in both cases. The newly
developed models therefore represent promising platforms for
further mechanistic studies of liver function.
With human metabolic models coming of age, medical,
diagnostic andpharmaceuticalapplicationsarenowbecoming
feasible.Networkmodelsofferastructuralscaffoldontowhich
high-throughput data sets can be mapped in order to analyze
experimental ﬁndings mechanistically. Hence, the impact of
structural network modiﬁcations and interventions by genetic
variation or drug administration can be investigated by
simulating the resulting effect on metabolic states. Potential
diagnostic applications are, for instance, model-based identi-
ﬁcation of speciﬁc biomarkers with altered levels in bioﬂuids
(Shlomi et al, 2009) or mapping of disease networks to human
metabolism (Lee et al, 2008).
Hepatic metabolism closely interacts with whole-body
physiology. Hence, the next step clearly requires moving from
the cellular level to the organ scale, for example by considera-
tion of hepatic zonation, and ultimately expansion to the
organism level (Figure 1). With such fully integrated models,
it will be possible to analyze hepatic metabolism in a clinical,
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metabolic activity on pharmacokinetic drug distribution or,
contrariwise, investigate changes in biomarker levels in
response to external stimuli (de Graaf et al, 2009).
Population-wide genotype information regarding metabolic
activity hasalready beenused inwhole-body models (Willmann
et al, 2009). There is reasonable hope that, in future, such
computer-based models will greatly help to mechanistically
explain pathophysiological states and support the development
of targeted therapeutic strategies. With the genome-scale
representations of hepatic metabolism by Gille et al and Jerby
et al at hand, detailed models will become available, assigning a
speciﬁc genetic background to an observed phenotype. Ulti-
mately, such multiscale models will help to explain the complex
interactions ofthevariousnetworks in the human bodyfromthe
cellular level up to the organism scale in an integrative way,
thereby creating a comprehensive picture of whole-body
physiology in its entirety.
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Figure 1 A multiscale representation of human physiology. Genome-scale
models of human liver metabolism can be incorporated inorgan models andmay
then be analyzed at a whole-body context. Speciﬁc phenotypes observed in
population-wide studies (marked in blue and green) can thus be assigned
mechanistically to a particular genotype.
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